Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%
U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision.
Livent Q1 EPS $0.28 Beats $0.14 Estimate, Sales $143.50M Beat $140.15M Estimate; Raises Guidance
Livent (NYSE:LTHM) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.14 by 100 percent. This is a 1300 percent increase over earnings of $0.02 per share from the same period
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Why Now Is The Time To Watch These 8 Lithium Stocks
During the Tesla Inc (NASDAQ: TSLA) earnings call on Wednesday, CEO Elon Musk asked for more public investments in the lithium mining industry.
Tesla CEO Musk On Price Of Lithium Says Tesla Might Actually Have To Get Into Mining & Refining Directly At Scale, Unless Costs Improve
https://twitter.com/elonmusk/status/1512505545416224783?s=20&t=aiW8yMQLTwqndRUZb6-FKA
Why This Boring Sector Could Be A Top Trender In The Next Few Years
The metals and mining sector may not be the most exciting group of assets at the moment, but that could change in the coming years.
The increasing demand for mining commodities has been driven by the global efforts for green energy. S&P Global suspects that supply constraints will send metals to above-average prices through 2025.
Battery/Lithium/Charging-Related Stocks Relatively Quiet Following Earlier Report ‘Biden Administration Drafting Order to Invoke Defense Production Act for Green Energy Storage Technology’
https://theintercept.com/2022/03/24/biden-defense-production-act-green-energy/
What 4 Analyst Ratings Have To Say About Livent
Over the past 3 months, 4 analysts have published their opinion on Livent (NYSE:LTHM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Mizuho Maintains Neutral on Livent, Lowers Price Target to $26
Mizuho analyst Christopher Parkinson maintains Livent (NYSE:LTHM) with a Neutral and lowers the price target from $31 to $26.